IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+5.7%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
(+0.18%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-3.84%
Top 10 Holdings %
Top 10 Hldgs %
54.1%
Holding
70
New
14
Increased
14
Reduced
8
Closed
4
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$6.81M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$6.23M |
| 3 |
Incyte
INCY
|
$4.95M |
| 4 |
Harmony Biosciences
HRMY
|
$4.69M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$3.81M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$16M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$14.5M |
| 3 |
Exelixis
EXEL
|
$14.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$8.16M |
| 5 |
Illumina
ILMN
|
$6.26M |
Sector Composition
| 1 | Healthcare | 98.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $27.7M | 7.32% | 402,784 +15,000 | +4% | +$1.03M |
|
|
2
Alnylam Pharmaceuticals
ALNY
$58.5B
| $25.2M | 6.66% | 149,000 +40,200 | +37% | +$6.81M |
|
|
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
| $22.9M | 6.04% | 145,000 +12,000 | +9% | +$1.89M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $22.3M | 5.88% | 237,873 -155,127 | -39% | -$14.5M |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $20.8M | 5.49% | 37,200 -6,600 | -15% | -$3.69M |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $20.1M | 5.31% | 207,000 | – | – |
|
7
PTC Therapeutics
PTCT
$3.92B
| $18.9M | 5% | 449,000 +41,000 | +10% | +$1.73M |
|
|
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $17.1M | 4.52% | 176,400 | – | – |
|
9
Biogen
BIIB
$19.4B
| $16.8M | 4.43% | 48,500 | – | – |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $13.1M | 3.45% | 64,822 -20,500 | -24% | -$4.13M |
|
11
Amgen
AMGN
$155B
| $12.4M | 3.28% | 51,000 +8,000 | +19% | +$1.95M |
|
|
12
Incyte
INCY
$16.5B
| $11.5M | 3.04% | 136,860 +58,860 | +75% | +$4.95M |
|
13
uniQure
QURE
$896M
| $9.71M | 2.56% | 315,500 +33,466 | +12% | +$1.03M |
|
|
TPTX
14
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.48M | 2.5% | 121,541 +40,000 | +49% | +$3.12M |
|
15
United Therapeutics
UTHR
$13.8B
| $7.77M | 2.05% | 43,300 +16,700 | +63% | +$3M |
|
|
XLRN
16
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.59M | 2% | 60,500 | – | – |
|
17
Ionis Pharmaceuticals
IONS
$6.8B
| $7.25M | 1.91% | 181,781 -152,000 | -46% | -$6.06M |
|
18
Protagonist Therapeutics
PTGX
$3.67B
| $6.81M | 1.8% | 152,000 | – | – |
|
19
KalVista Pharmaceuticals
KALV
$678M
| $6.79M | 1.79% | 283,233 +68,700 | +32% | +$1.65M |
|
|
20
Supernus Pharmaceuticals
SUPN
$2.53B
| $6.23M | 1.65% | +202,436 | New | +$6.23M |
|
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $5.73M | 1.51% | 60,100 +40,000 | +199% | +$3.81M |
|
|
22
Harmony Biosciences
HRMY
$2.12B
| $4.69M | 1.24% | +166,000 | New | +$4.69M |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.6M | 1.22% | 55,156 | – | – |
|
|
CCXI
24
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.04M | 1.07% | 58,100 -230,500 | -80% | -$16M |
|
25
Aurinia Pharmaceuticals
AUPH
$1.58B
| $3.87M | 1.02% | 298,500 | – | – |
|